Orpyx was honored with $20k at the TEC Edmonton VenturePrize Awards in the Student Business Plan category. The competition included a gamut of impressive technology start-ups from across the province pitching their concepts to a roomful of technology movers and shakers.
Calgary, AB - May 7, 2012 - Orpyx Medical Technologies was one of a number of Alberta-based companies competing for cash and in-kind goods and services at the 10th Annual TEC Edmonton VenturePrize Awards in Edmonton last week. TEC VenturePrize is a program of TEC Edmonton, providing training, professional support and financial incentives to help people build or enhance a viable technology-based business. The competition marked the final round of a series of regional business plan competitions held in the months leading up to the VenturePrize event. After winning the Calgary-region Student Technology Innovation Challenge (STIC) in February, Dr. Breanne Everett presented Orpyx’s business plan to a panel of judges in Edmonton. After an amazing evening packed with inspirational speeches and presentations, Orpyx was announced as the winner in their category.
“We are so thrilled and honoured to have been recognized at the VenturePrize Awards, among a truly amazing group of up-and-coming companies,” says Dr. Breanne Everett, CEO and President, Orpyx Medical Technologies. “TEC Edmonton has been such a supportive community—a tremendous asset to an emerging company. It's a very exciting time to be in Alberta and part of the growing innovation scene.”
The other two companies competing in the Student Business Plan finals were CitizenBridge from the University of Lethbridge, and ENERCAL Data Systems from the University of Calgary. Everyone in attendance agreed that without the resources, mentorship and financial support made available through agencies such TEC Edmonton and Innovate Calgary, the viability of tech-based businesses in Alberta would be substantially compromised. Orpyx plans on applying their VenturePrize Award towards their technology development costs and commercialization goals for late 2012.
VP Marketing, Orpyx Medical Technologies Inc.
M (403) 805-6446
O (403) 709-0129
Orpyx was created out of a profound desire to address the swiftly-growing global diabetes epidemic and its related complications, notably that of diabetic peripheral neuropathy – loss of feeling and sensory feedback in the feet experienced by an estimated 50-percent of the 350 million diabetics worldwide, that can lead to tissue damage, infection, ulceration and amputation.
Founded by 27-year-old Calgary surgical resident Dr. Breanne Everett, Orpyx is behind two highly innovative plantar sensory replacement systems, the SurroSense Rx and the SurroGait Rx, that use pressure sensor-embedded shoe insoles to determine force exerted over the bottom of the feet, and wirelessly transmit collected information to a back pad, mobile device or wristwatch worn by the user using the ANT+ wireless technology protocol. Employing the phenomenon of neuroplasticity – the potential of the human brain to rewire itself, the patient is able to interpret the sensory stimulus felt on the back as that from the feet, and positively adjust their gait, balance, mobility and overall health as a result.